The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram-negative and haematogenous osteomyelitis

A H Montes1, Victor Asensi, Victoria Alvarez

  • 1Department of Biochemistry and Molecular Biology, Oviedo University Medical School and Hospital Central de Asturias, Oviedo, Spain.

Insights

The Toll-like receptor 4 (TLR4) Asp299Gly polymorphism is linked to increased susceptibility to Gram-negative and chronic osteomyelitis. This genetic variation impacts neutrophil function, potentially affecting infection outcomes.

Area of Science:

  • Immunogenetics
  • Infectious Diseases
  • Molecular Biology

Background:

  • Osteomyelitis is a bone infection often caused by Staphylococcus aureus or Gram-negative bacteria.
  • Toll-like receptors (TLRs) play a crucial role in the innate immune response by recognizing microbial products and activating signaling pathways like NF-kappaB.
  • Genetic variations in TLRs, such as polymorphisms in TLR2 and TLR4, have been associated with susceptibility to bacterial infections.

Purpose of the Study:

  • To investigate the association between specific TLR2 and TLR4 gene polymorphisms and osteomyelitis in patients.
  • To determine if these polymorphisms influence susceptibility to Gram-negative bacteria, hematogenous spread, or chronic forms of osteomyelitis.
  • To analyze the functional consequences of the TLR4 Asp299Gly polymorphism on neutrophil responses.

Main Methods:

  • Genotyping of TLR2 (Arg753Gln) and TLR4 (Asp299Gly, Thr399Ile) polymorphisms in 80 osteomyelitis patients and 155 healthy controls.
  • Statistical analysis to compare genotype frequencies between patients and controls.
  • Functional assays on neutrophils from patients homozygous for the TLR4 Asp299Gly polymorphism, assessing lipopolysaccharide (LPS)-induced apoptosis, NF-kappaB inhibitor phosphorylation, and cytokine levels (IL-6, TNF-alpha).

Main Results:

  • Homozygosity for the TLR4 Asp299Gly polymorphism was significantly more frequent in osteomyelitis patients (3.8%) compared to controls (0%, P = 0.038).
  • Carriers of the TLR4 Asp299Gly allele were more likely to have Gram-negative, hematogenous, and/or chronic osteomyelitis (P < 0.031).
  • Neutrophils from TLR4 Asp299Gly homozygous patients exhibited reduced LPS-induced apoptosis reduction and lower levels of IL-6 and TNF-alpha.

Conclusions:

  • The TLR4 Asp299Gly polymorphism is associated with an increased risk of developing Gram-negative and hematogenous osteomyelitis.
  • This genetic variation may influence disease progression and severity by altering innate immune cell function.
  • No association was found between the TLR2 Arg753Gln polymorphism and osteomyelitis in this cohort.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...